-
Product Insights
Membranous Glomerulonephritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Membranous Glomerulonephritis - Drugs In Development, 2023’, provides an overview of the Membranous Glomerulonephritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Membranous Glomerulonephritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Drugs In Development, 2023’, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Peripheral Neuropathy (Sensory Neuropathy) – Drugs In Development, 2023
Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Drugs In Development, 2023’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peripheral Neuropathy (Sensory Neuropathy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Glomerulonephritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Glomerulonephritis - Drugs In Development, 2023’, provides an overview of the Glomerulonephritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glomerulonephritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Neuropathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Neuropathy - Drugs In Development, 2023’, provides an overview of the Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuropathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Neuromyelitis Optica (Devic’s Syndrome) Disease – Global Clinical Trials Review, H2 2020
GlobalData's clinical trial report, “Neuromyelitis Optica (Devic’s Syndrome) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Neuromyelitis Optica (Devic’s Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic’s Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
Pemphigus Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pemphigus Global Clinical Trials Review, H1, 2018" provides an overview of Pemphigus clinical trials scenario. This report provides top line data relating to the clinical trials on Pemphigus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review, H1, 2018" provides an overview of Neuromyelitis Optica (Devic’s Syndrome) clinical trials scenario. This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic’s Syndrome). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2017" provides an overview of Granulomatosis with Polyangiitis (Wegener Polyangiitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Granulomatosis with Polyangiitis (Wegener Polyangiitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Global Clinical Trials Review, H2, 2018" provides an overview of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) clinical trials scenario. This report provides top line data relating to the clinical trials on Granulomatosis with Polyangiitis (Wegener's Granulomatosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...